biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Amazingly….

<< Previous

Bullboard Posts

Next >>

Comment by lovingoldon Feb 20, 2022 2:18pm

84 Views

Post# 34446462

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Amazingly….

The answer for longs is "can't" not "won't". Otherwise you would've done so already. I've done my DD and have come to the conclusion nothing is happening. You can't refute it so just sit down and watch your stock do nothing for another 10 years.

Great job!
So are you looking for an award for your work?
If you've done your DD and have come to that conclusion then be gone with you.
Why are you still discussing it on this board?
Are you looking for validation for your research? Maybe share this insight about Bioasis with your friends and impress them with what you know and how you avoided disaster by holding or buying shares.

You seem pretty set in your beliefs so why should we bother to change your mind?

Why don't you go read the latest Zachs research report from a couple of weeks ago and see why they have a price target of $.60 USD RIGHT NOW - that is triple our current share price and they say we should be trading at that price right now based on current public information, not anything that might surprise the market.